UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 72

Sortiert nach

The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis

Multiple sclerosis, 2011-08, Vol.17 (8), p.949-957

2011

Volltextzugriff (PDF)

Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome

Multiple sclerosis journal - experimental, translational and clinical, 2022-01, Vol.8 (1), p.20552173221078834-20552173221078834

2022

Volltextzugriff (PDF)

Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials

Multiple sclerosis journal - experimental, translational and clinical, 2017-12, Vol.3 (4), p.2055217317745340-2055217317745340

2017

Volltextzugriff (PDF)

What Have We Learned from Perfusion MRI in Multiple Sclerosis?

American journal of neuroradiology : AJNR, 2018-06, Vol.39 (6), p.994-1000

2018

Volltextzugriff (PDF)

Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

Multiple sclerosis, 2022-03, Vol.28 (3), p.418-428

2022

Volltextzugriff (PDF)

Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology

Multiple sclerosis, 2006-12, Vol.12 (6), p.747-753

2006

Volltextzugriff (PDF)

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

BMC neurology, 2008-04, Vol.8 (1), p.11-11, Article 11

2008

Volltextzugriff (PDF)

Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

Multiple sclerosis, 2016-01, Vol.22 (1), p.112-116

2016

Volltextzugriff (PDF)

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

Neurology, 2006-05, Vol.66 (9), p.1384

2006

Volltextzugriff (PDF)

Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

Multiple sclerosis, 2010-06, Vol.16 (6), p.670-677

2010

Volltextzugriff (PDF)

Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results

Neurology, 2001-06, Vol.56 (11), p.1505

2001

Volltextzugriff (PDF)

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

Neurology, 2001-06, Vol.56 (12), p.1628

PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group

2001

Volltextzugriff (PDF)

In vivo measurement of T 2 distributions and water contents in normal human brain

Magnetic resonance in medicine, 1997-01, Vol.37 (1), p.34-43

1997

Volltextzugriff (PDF)

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes

Multiple sclerosis, 2014-04, Vol.20 (4), p.458-463

2014

Volltextzugriff (PDF)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis

The Lancet (British edition), 1998-11, Vol.352 (9139), p.1498

1998

Volltextzugriff (PDF)

Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis

Neurology, 2011-12, Vol.77 (24), p.2089

2011

Volltextzugriff (PDF)

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

Neurology, 2002-09, Vol.59 (6 Suppl 3), p.S1

O'Connor, Paul

2002

Volltextzugriff (PDF)

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

Neurology, 1999-08, Vol.53 (3), p.448

1999

Volltextzugriff (PDF)

Does MRI lesion activity regress in secondary progressive multiple sclerosis?

Multiple sclerosis, 2010-04, Vol.16 (4), p.434-442

2010

Volltextzugriff (PDF)

A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain

Neurology, 2000-11, Vol.55 (10), p.1506

2000

Volltextzugriff (PDF)

Dirty-appearing white matter in multiple sclerosis

Journal of neurology, 2008-11, Vol.255 (11), p.1802-1811

2008

Volltextzugriff (PDF)

Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup

Dementia and geriatric cognitive disorders, 2008-03, Vol.25 (3), p.238

2008

Volltextzugriff (PDF)

Proton T 1 relaxation times of cerebral metabolites differ within and between regions of normal human brain

NMR in biomedicine, 2003-12, Vol.16 (8), p.503-509

2003

Volltextzugriff (PDF)

A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients

Magnetic resonance in medicine, 1998-11, Vol.40 (5), p.763-768

1998

Volltextzugriff (PDF)

Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis

Journal of neurology, 2003-08, Vol.250 (8), p.924-931

2003

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(72)

Sprache

Englisch
(72)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Humans
(60)
Female
(40)
Male
(37)
Neurosciences & Neurology
(37)
Biological And Medical Sciences
(36)
Clinical Neurology
(36)
Medical Sciences
(36)
Adult
(35)
Magnetic Resonance Imaging
(32)
Middle Aged
(31)
Radiology, Nuclear Medicine & Medical Imaging
(25)
Brain - Pathology
(23)
Neurology
(23)
Multiple Sclerosis - Diagnosis
(17)
Multiple Sclerosis - Pathology
(14)
Multiple Sclerosis
(13)
Neurosciences
(13)
Aged
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis

Quantitative MRI findings indicate diffuse white matter damage in Susac Syndrome

Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials

What Have We Learned from Perfusion MRI in Multiple Sclerosis?

Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging

Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology

Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis

Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS

In vivo measurement of T 2 distributions and water contents in normal human brain

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis

Evaluation of safety monitoring guidelines based on MRI lesion activity in multiple sclerosis

Key issues in the diagnosis and treatment of multiple sclerosis. An overview

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

Does MRI lesion activity regress in secondary progressive multiple sclerosis?

A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain

Dirty-appearing white matter in multiple sclerosis

Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup

Proton T 1 relaxation times of cerebral metabolites differ within and between regions of normal human brain

A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients

Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis

Suchergebnisse filtern